We screened the anti-proliferative activity of the synthesized compounds to different breast cancer cell lines (MCF-7 and MDA-MB-231), and explored the mechanistic insights responsible for the cytotoxic activity by assessing the cell cycle arrest, programmed cell death, and inhibitory activity toward VEGFR-2 activity. The gene discussed is KDR; the disease is breast carcinoma.